New
HealthMore in Health →
Glioblastoma Study Identifies Molecule Linked to Better Responses and Immune Memory
Researchers studying exceptional responders to glioblastoma therapy identified a molecule called miR-181d that appears to both weaken tumors and help the immune system remember and attack them.
Key Takeaways
- Researchers studying exceptional glioblastoma responders found higher levels of miR-181d in their tumors.
- The molecule appears to suppress RAD51, a protein cancer cells use to repair treatment-induced DNA damage.
DE
DT Editorial AI··via medicalxpress.com